Have a personal or library account? Click to login
Asbestos Consumption and Malignant Mesothelioma Mortality Trends in the Major User Countries Cover

Asbestos Consumption and Malignant Mesothelioma Mortality Trends in the Major User Countries

Open Access
|Feb 2023

References

  1. 1Chimed-Ochir O, Takahashi K, Driscoll TR, Takala J, GBD Mortality and causes of Death Collaborators. Global, regional, and national age-sex specific all cause and cause specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the global burden of disease study 2013. Lancet. 2015; 385: 117171. DOI: 10.1016/S0140-6736(14)61682-2
  2. 2International Agency for Research on Cancer (IARC). Arsenic, Metals, Fibres and Dusts: A Review of Human Carcinogens. 2012. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No 100C. http://monographs.iarc.fr/ENG/Monographs/vol100C/mono100C.pdf. Accessed December 29, 2018. DOI: 10.1016/S0140-6736(07)60412-7
  3. 3Lin RT, Takahashi K, Karjalainen A, et al. Ecological association between asbestos related diseases and historical asbestos consumption: an international analysis. Lancet. 2007; 369: 8449.
  4. 4International Labour Organization/World Health Organization. Outline for the Development of National Programmes for the Elimination of Asbestos-Related Diseases. Geneva, Switzerland: International Labour Organization/World Health Organization; 2007. http://www.who.int/occupational_health/publications/Out_NPEAD_ENG.
  5. 5Collegium Ramazzini. Call for ban: Call for an international ban on asbestos. Scand J Work Environ Health. 1999; 25(6): 6335.
  6. 6United States Geological Survey (USGS). 2015 Minerals Yearbook: Asbestos. https://minerals.usgs.gov/minerals/pubs/commodity/asbestos/myb1-2015-asbes.pdf; 2016.
  7. 7Oddone E, Bollon J, Nava CR, et al. Effect of Asbestos Consumption on Malignant Pleural Mesothelioma in Italy: Forecasts of Mortality up to 2040. Cancers. 2021; 13: 3338. DOI: 10.3390/cancers13133338
  8. 8Marinaccio A, Binazzi A, Marzio DD, et al. Pleural malignant mesothelioma epidemic: incidence, modalities of asbestos exposure and occupations involved from the Italian National Register. Int J Cancer. 2012; 130(9): 214654. Epub 2011 Sep 27. PMID: 21647880. DOI: 10.1002/ijc.26229
  9. 9https://www.who.int/data/data-collection-tools/who-mortality-database.
  10. 10https://it.zhujiworld.com/.
  11. 11Gasparrini A. Modeling Exposure-Lag-Response Associations with Distributed Lag Non-Linear Models. Stat. Med. 2014; 33: 881899. DOI: 10.1002/sim.5963
  12. 12Gasparrini A, Armstrong B. Reducing and meta-analysing estimates from distributed lag non-linear models. BMC Med Res Methodol. 2013; 13(1). DOI: 10.1186/1471-2288-13-1
  13. 13Delgermaa V, Takahashi K, Park EK, et al. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Health Organ. 2011; 89: 71624. DOI: 10.2471/BLT.11.086678
  14. 14Odgerel CO, Takahashi K, Sorahan T, et al. Estimation of the global burden of mesothelioma deaths from incomplete national mortality data. Occup Environ Med. 2017 Dec; 74(12): 851858. Epub 2017 Sep 2. PMID: 28866609; PMCID: PMC5740549. DOI: 10.1136/oemed-2017-104298
  15. 15Park EK, Takahashi K, Hoshuyama T, et al. Global magnitude of reported and unreported mesothelioma. Environ Health Perspect. 2011; 119(4): 5148. DOI: 10.1289/ehp.1002845
  16. 16Takahashi K, Huuskonen M, Tossavainen A, Higashi T, Okubo T, Rantanen J. Ecological relationship between mesothelioma incidence/mortality and asbestos consumption in ten Western countries and Japan. J Occup Health. 1999; 41(1): 811. DOI: 10.1539/joh.41.8
  17. 17Marinaccio A, Montanaro F, Mastrantonio M, et al. Predictions of mortality from pleural mesothelioma in Italy: a model based on asbestos consumption figures supports results from age-period-cohort models. Int J Cancer. 2005; 115(1): 1427. PMID: 15645436. DOI: 10.1002/ijc.20820
  18. 18Murayama T, Takahashi K, Natori Y, Kurumatani N. Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort-model. Am J Ind Med. 2006; 49: 17. DOI: 10.1002/ajim.20246
  19. 19Tan E, Warren N, Darnton AJ, Hodgson JT. Projection of mesothelioma mortality in Britain using Bayesian methods. Br J Cancer. 2010; 103: 4306. DOI: 10.1038/sj.bjc.6605781
  20. 20Jung SH, Kim HR, Koh SB, et al. A decade of malignant mesothelioma surveillance in Korea. Am J Ind Med. 2012 Oct; 55(10): 86975. DOI: 10.1002/ajim.22065
  21. 21Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg. 2000; 44(8): 565601. PMID: 11108782. DOI: 10.1016/S0003-4878(00)00045-4
  22. 22Garabrant DH, Pastula ST. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans. Toxicol Appl Pharmacol. 2018; 361: 127136. Epub 2018 Aug 2. PMID: 30077661. DOI: 10.1016/j.taap.2018.07.003
  23. 23Korchevskiy A, Rasmuson JO, Rasmuson EJ, Strode RD. Inhalation unit risk (IUR) of asbestos based on available science. Inhal Toxicol. 2020 A; 32(9–10): 372374. Epub 2020 Oct 9. PMID: 33032452. DOI: 10.1080/08958378.2020.1829210
  24. 24Dalsgaard SB, Würtz ET, Hansen J, Røe OD, Omland Ø. Environmental asbestos exposure in childhood and risk of mesothelioma later in life: a long-term follow-up register-based cohort study. Occup Environ Med. 2019; 76(6): 407413. Epub 2019 Feb 25. PMID: 30804166. DOI: 10.1136/oemed-2018-105392
  25. 25Reid A, Franklin P, Olsen N, et al. All-cause mortality and cancer incidence among adults exposed to blue asbestos during childhood. Am J Ind Med. 2013; 56(2): 13345. Epub 2012 Aug 9. PMID: 22886909. DOI: 10.1002/ajim.22103
  26. 26Reid A, Franklin P, Berry G, et al. Are children more vulnerable to mesothelioma than adults? A comparison of mesothelioma risk among children and adults exposed non-occupationally to blue asbestos at Wittenoom. Occup Environ Med. 2018; 75(12): 898903. Epub 2018 Aug 29. PMID: 30158318. DOI: 10.1136/oemed-2018-105108
  27. 27Berman DW, Crump KS. Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol. 2008; 38(1): 147. PMID: 18671157. DOI: 10.1080/10408440802276167
  28. 28Korchevskiy AA, Wylie AG. Dimensional determinants for the carcinogenic potency of elongate amphibole particles. Inhal Toxicol. 2021; 33(6–8): 244259. Epub 2021 Oct 6. PMID: 34612763. DOI: 10.1080/08958378.2021.1971340
  29. 29Korchevskiy AA, Wylie AG. Dimensional characteristics of the major types of amphibole mineral particles and the implications for carcinogenic risk assessment. Inhal Toxicol. 2022; 34(1–2): 2438. Epub 2022 Jan 10. PMID: 35001771. DOI: 10.1080/08958378.2021.2024304
  30. 30Berman DW, Crump KS. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Crit Rev Toxicol. 2008; 38(1): 4973. PMID: 18686078. DOI: 10.1080/10408440802273156
  31. 31http://www.ibasecretariat.org/.
DOI: https://doi.org/10.5334/aogh.4012 | Journal eISSN: 2214-9996
Language: English
Submitted on: Nov 8, 2022
Accepted on: Jan 25, 2023
Published on: Feb 13, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2023 Claudio Gariazzo, Antonio Gasparrini, Alessandro Marinaccio, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.